Global cross-sectional study of the burden of disease in adolescent and adult patients with atopic dermatitis (MEASURE AD)
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: ABBVIE SPAIN SLU
- Execution start: 19/03/2020
- End of execution: 30/09/2020
- PI: RICARDO RUIZ VILLAVERDE
